4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-23-005546
CIK 0000894158other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:08 AM ET
Size
5.0 KB
Accession
0001104659-23-005546
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Purchase
Common Stock
2023-01-20$0.75/sh+25,000$18,705→ 135,000 total
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:08 AM ET
- Size
- 5.0 KB